Additional file 1 of Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling

Additional file 1: Fig. S1. WGCNA revealed the prominent genes correlated with EC according to the GSE17025 dataset. Fig. S2. The association between the biological processes, signaling pathways, and MYH14 expression in EC. Fig. S3. MYH14 levels were potentially associated with EC chemoresistance. Fig. S4. Effects of carboplatin and paclitaxel on EC cell viability. Table S1. A list of antibodies used in this study. Table S2. The primers used in this study. Table S3. A list of genes belonging to the myosin family. Table S4. The correlation between MYH14 and Ki67 expression in endometrial cancer.